Germany
Japan
United Kingdom
China
OLIG2 mouse monoclonal antibody,clone UMAB294
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Products
Desmin(DES) mouse monoclonal antibody,clone UMAB302
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Calcitonin(CALCA) mouse monoclonal antibody,clone UMAB303
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
INHA mouse monoclonal antibody,clone UMAB304
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Calretinin(CALB2) mouse monoclonal antibody,clone UMAB305
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Calretinin(CALB2) mouse monoclonal antibody,clone UMAB306
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
SALL4 mouse monoclonal antibody,clone UMAB307
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 379.00
2 Weeks
USD 379.00
2 Weeks
GCDFP-15(PIP) Rabbit monoclonal antibody,clone UMAB298
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 150.00
2 Weeks
GS(Glul) Rabbit monoclonal antibody,clone UMAB296
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 150.00
2 Weeks
GS(Glul) Rabbit monoclonal antibody,clone UMAB297
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
GCDFP-15(PIP) Rabbit monoclonal antibody,clone UMAB298
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
BCL6 Rabbit monoclonal antibody,clone UMAB299
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
STAT6 Rabbit monoclonal antibody,clone UMAB300
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
PAX2 Rabbit monoclonal antibody,clone UMAB301
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- IHC
Filter by
Target Symbol
- MAP2K1 (189)
- TP53 (160)
- MKI67 (147)
- NME1 (137)
- KRT19 (131)
- MSMB (123)
- OTC (119)
- ERBB2 (118)
- TG (118)
- LIPG (117)
- KLK8 (114)
- PECAM1 (114)
- NBN (110)
- PGR (110)
- MAP2K3 (101)
- CD4 (98)
- CTAG1B (97)
- CDKN2A (94)
- ABCB1 (92)
- CTNNB1 (89)
- AKT1 (86)
- CD99 (86)
- PTPRC (84)
- CHGA (82)
- ADIPOQ (81)
- PCNA (78)
- BCL2 (77)
- LGALS3 (77)
- APP (76)
- JUN (76)
- ERCC1 (75)
- VSNL1 (74)
- EGFR (73)
- NKX3-1 (73)
- PIK3C2A (73)
- TOP2A (70)
- KRT20 (69)
- MLANA (65)
- SENP2 (65)
- KIT (64)
- CD68 (62)
- KRT18 (62)
- NCAM1 (62)
- S100A9 (62)
- CD44 (61)
- CDH1 (60)
- MS4A1 (60)
- BSG (59)
- EPCAM (59)
- MEF2C (59)
- ESR1 (58)
- PDCD1 (58)
- AGR2 (56)
- MDM4 (56)
- PIK3CG (56)
- ABAT (55)
- BBOX1 (55)
- LOX (55)
- MUC1 (55)
- BTK (54)
- CD163 (54)
- KRT7 (54)
- MCM2 (54)
- MGLL (54)
- MTOR (54)
- RTRAF (54)
- TYMP (54)
- BUB1B (53)
- CTSL (53)
- F13A1 (53)
- PFKP (53)
- SQSTM1 (53)
- SYP (53)
- VBP1 (53)
- CD8A (52)
- HSPD1 (52)
- LTA4H (52)
- MGMT (52)
- NPR3 (52)
- PDE4A (52)
- POR (52)
- PPP5C (52)
- PROCR (52)
- UBE2G2 (52)
- AKR1A1 (51)
- CR2 (51)
- PARVA (51)
- TYMS (51)
- GBP2 (50)
- GFAP (50)
- KRT5 (50)
- LPIN1 (50)
- NR3C1 (50)
- PTPRE (50)
- VWF (50)
- AMACR (49)
- CD63 (49)
- NAPSA (49)
- RET (49)
- CD40 (48)
Reactivities
- Human (53604)
- Mouse (34182)
- Rat (29165)
- Monkey (3229)
- Dog (2956)
- Bovine (648)
- Pig (372)
- Rabbit (230)
- Chicken (215)
- Hamster (197)
- Gorilla (179)
- Cow (168)
- Xenopus (165)
- Horse (145)
- Gibbon (141)
- Primate (129)
- Bat (118)
- Zebrafish (114)
- Rhesus Monkey (110)
- Chimpanzee (101)
- Canine (73)
- X. tropicalis (71)
- Porcine (67)
- Guinea Pig (51)
- Sheep (44)
- Orang-Utan (40)
- Feline (27)
- Other (Wide Range) (24)
- Mammalian (20)
- Drosophila (19)
- C. elegans (16)
- Equine (16)
- Goat (12)
- Macaque (11)
- Gerbil (7)
- Fish (6)
- Murine (6)
- Yeast (5)
- All Species (4)
- Cynomolgus (4)
- Opossum (4)
- Baboon (3)
- Ferret (3)
- Frog (3)
- Marmoset (3)
- SARS-CoV-2 (3)
- Avian (2)
- Broad (2)
- Dengue virus (2)
- Escherichia coli (2)
- Fusion proteins containing the Flag Tag (2)
- Plant (2)
- Quail (2)
- SARS-CoV (2)
- Virus (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- Amphibian (1)
- Beluga (1)
- Birds (1)
- Canis (1)
- Carp (1)
- Drosophila melanogaster (1)
- Fungi (1)
- Helicobacter pylori (1)
- Insect (1)
- Medaka fish (1)
- Mink (1)
- Pufferfish (1)
- Salmonella Typhimurium (1)
- Spinach (1)
- Squirrel (1)
- Staphylococcus aureus (1)
- Tadpole (1)
- Tree Shrew (1)
- Trichinella spiralis (1)
- Vertebrates (1)
- Whale (1)
- White Fly (1)
Antibody Hosts
Isotypes
- IgG (25029)
- IgG1 (21966)
- IgG2a (6402)
- IgG2b (5282)
- Ig (2366)
- IgG1, kappa (241)
- IgM (172)
- IgG3 (135)
- IgG, kappa (128)
- IgG2a, kappa (77)
- IgG2b, kappa (57)
- IgG2 (25)
- IgY (21)
- IgG2c (10)
- IgG3, kappa (9)
- IgM, kappa (9)
- IgG1, lambda (8)
- cocktail (4)
- IgG2a, lambda (2)
- IgG2b, lambda (2)
- IgA (1)
- IgA, kappa (1)
- IgE (1)
- IgG fraction (1)
- IgG1/IgK (1)
- IgG12b (1)
- IgG4 (1)
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
- Unmodified (2395)
- Phospho-specific (472)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (37)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (7)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- Acetyl K12 (2)
- Acetyl K5 (2)
- Phospho S127 (2)
- Phospho S39 (2)
- Phospho S727 (2)
- Phospho S795 (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- TriMethyl K56 (2)
- Acetyl K15 (1)
- Acetyl K18 (1)
- Acetyl K23 (1)
- Acetyl K27 (1)
- Acetyl K56 (1)
- Acetyl K8 (1)
- Acetyl K9 (1)
- Acetyl K9/K14/K18/K23/K27 (1)
- Asymmetric DiMethyl R3 (1)
- DiMethyl K385 (1)
- MonoMethyl K36 (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Pan DiMethyl-lysine (1)
- Phospho S1 (1)
- Phospho S10 (1)
- Phospho S10/T11 (1)
- Phospho S104 (1)
- Phospho S1177 (1)
- Phospho S1248 (1)
- Phospho S15 (1)
- Phospho S157 (1)
- Phospho S182 (1)
- Phospho S240/244 (1)
- Phospho S243 (1)
- Phospho S280 (1)
- Phospho S33 (1)
- Phospho S33/S37/T41 (1)
- Phospho S37 (1)
- Phospho S376 (1)
- Phospho S425 (1)
- Phospho S428 (1)
- Phospho S455 (1)
- Phospho S465/467 + S423/425 (1)
- Phospho S473 (1)
- Phospho S473,Phospho S474,Phospho S472 (1)
- Phospho S5 (1)
- Phospho S51 (1)
- Phospho S529 (1)
- Phospho S612 (1)
- Phospho S62 (1)
- Phospho S73 (1)
- Phospho S80 (1)
- Phospho S82 (1)
- Phospho S89 (1)
- Phospho S957 (1)
- Phospho Ser416 (1)
- Phospho T11 (1)
- Phospho T17 (1)
- Phospho T179 (1)
- Phospho T18/S19 (1)
- Phospho T183/T172 (1)
- Phospho T1989 (1)
- Phospho T202/Y204 + T185/Y187 (1)
- Phospho T24,Phospho T32,Phospho T28 (1)
- Phospho T286 (1)
- Phospho T308 (1)
- Phospho T32 (1)
- Phospho T320 (1)
- Phospho T37/46 (1)
- Phospho T389 (1)
- Phospho T45 (1)
- Phospho T58 (1)
- Phospho T6 (1)
- Phospho T69/71 (1)
- Phospho T69/T71 (1)
- Phospho T70 (1)
- Phospho T91 (1)
- Phospho Y1007/1008 (1)
- Phospho Y1217 (1)
- Phospho Y1349 (1)
- Phospho Y15 (1)
- Phospho Y182 (1)
- Phospho Y207 (1)
- Phospho Y245 (1)
- Phospho Y412 (1)
- Phospho Y694 (1)
- Phospho Y705 (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- phospho T1079,Phospho T1041 (1)
Assay Types
Families
- Druggable Genome (27977)
- Transmembrane (10175)
- Transcription Factors (6525)
- Secreted Protein (4472)
- ES Cell Differentiation/IPS (3712)
- Protein Kinase (3218)
- Protease (2074)
- Stem cell - Pluripotency (2008)
- Adult stem cells (828)
- GPCR (774)
- Embryonic stem cells (528)
- Nuclear Hormone Receptor (515)
- Phosphatase (452)
- Cancer stem cells (408)
- Induced pluripotent stem cells (311)
- P450 (289)
- Stem cell relevant signaling - JAK/STAT signaling pathway (267)
- Stem cell relevant signaling - DSL/Notch pathway (226)
- Ion Channels: Other (221)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (139)
- Ion Channels: Potassium (101)
- Stem cell relevant signaling - Wnt Signaling pathway (100)
- Ion Channels: Transient receptor potential (93)
- Ion Channels: Cys-loop Receptors (59)
- Ion Channels: Glutamate Receptors (52)
- Ion Channels: Sodium (27)
- Ion Channels: Calcium (11)
- Ion Channels: Cyclic nucleotide gated (11)
- Ion Channels: ATP Receptors (10)
Pathways
- Metabolic pathways (4704)
- Pathways in cancer (3594)
- MAPK signaling pathway (2079)
- Focal adhesion (1960)
- Prostate cancer (1739)
- Neurotrophin signaling pathway (1479)
- Colorectal cancer (1451)
- T cell receptor signaling pathway (1414)
- ErbB signaling pathway (1382)
- Pancreatic cancer (1342)
- Regulation of actin cytoskeleton (1339)
- Toll-like receptor signaling pathway (1338)
- Chronic myeloid leukemia (1294)
- Melanoma (1281)
- Endometrial cancer (1241)
- Insulin signaling pathway (1233)
- Glioma (1202)
- Cell adhesion molecules (CAMs) (1194)
- Cytokine-cytokine receptor interaction (1172)
- Non-small cell lung cancer (1170)
- Bladder cancer (1140)
- Cell cycle (1133)
- B cell receptor signaling pathway (1131)
- Chemokine signaling pathway (1131)
- Progesterone-mediated oocyte maturation (1098)
- Apoptosis (1082)
- Acute myeloid leukemia (1064)
- Hematopoietic cell lineage (1020)
- Fc gamma R-mediated phagocytosis (1007)
- Fc epsilon RI signaling pathway (966)
- Small cell lung cancer (966)
- Wnt signaling pathway (961)
- Leukocyte transendothelial migration (954)
- Renal cell carcinoma (937)
- Jak-STAT signaling pathway (926)
- Endocytosis (914)
- Natural killer cell mediated cytotoxicity (872)
- Alzheimer's disease (866)
- GnRH signaling pathway (833)
- VEGF signaling pathway (822)
- p53 signaling pathway (796)
- Huntington's disease (781)
- Melanogenesis (779)
- Amyotrophic lateral sclerosis (ALS) (753)
- Oocyte meiosis (753)
- Neuroactive ligand-receptor interaction (735)
- Gap junction (731)
- Adherens junction (726)
- Calcium signaling pathway (721)
- Thyroid cancer (720)
- Adipocytokine signaling pathway (692)
- Purine metabolism (683)
- mTOR signaling pathway (648)
- Ubiquitin mediated proteolysis (581)
- Type II diabetes mellitus (579)
- Vascular smooth muscle contraction (572)
- Pyrimidine metabolism (568)
- Tight junction (538)
- Pathogenic Escherichia coli infection (535)
- Axon guidance (529)
- Epithelial cell signaling in Helicobacter pylori infection (520)
- Parkinson's disease (514)
- Long-term potentiation (513)
- Glycolysis / Gluconeogenesis (505)
- Long-term depression (505)
- Complement and coagulation cascades (495)
- Basal cell carcinoma (489)
- Primary immunodeficiency (483)
- Prion diseases (474)
- Arginine and proline metabolism (455)
- TGF-beta signaling pathway (451)
- Lysosome (446)
- Antigen processing and presentation (440)
- RIG-I-like receptor signaling pathway (434)
- Systemic lupus erythematosus (428)
- ECM-receptor interaction (411)
- NOD-like receptor signaling pathway (399)
- Dilated cardiomyopathy (387)
- Hypertrophic cardiomyopathy (HCM) (387)
- Valine (377)
- leucine and isoleucine degradation (370)
- PPAR signaling pathway (360)
- Drug metabolism - cytochrome P450 (354)
- Glycerolipid metabolism (350)
- Oxidative phosphorylation (350)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (349)
- Dorso-ventral axis formation (346)
- Metabolism of xenobiotics by cytochrome P450 (345)
- Phosphatidylinositol signaling system (339)
- Nucleotide excision repair (331)
- Cytosolic DNA-sensing pathway (327)
- Fatty acid metabolism (314)
- Viral myocarditis (313)
- Tryptophan metabolism (308)
- Autoimmune thyroid disease (305)
- Arachidonic acid metabolism (302)
- Alanine (271)
- Spliceosome (271)
- aspartate and glutamate metabolism (271)
- Lysine degradation (270)
- Inositol phosphate metabolism (269)
- Type I diabetes mellitus (266)
- Hedgehog signaling pathway (261)
- RNA degradation (257)
- Butanoate metabolism (254)
- DNA replication (253)
- Glutathione metabolism (250)
- Propanoate metabolism (250)
- Mismatch repair (246)
- Tyrosine metabolism (243)
- Retinol metabolism (236)
- Pyruvate metabolism (235)
- Base excision repair (233)
- Histidine metabolism (219)
- Notch signaling pathway (212)
- Glycine (207)
- serine and threonine metabolism (207)
- Allograft rejection (204)
- Cardiac muscle contraction (201)
- Renin-angiotensin system (197)
- ABC transporters (186)
- Vibrio cholerae infection (183)
- Homologous recombination (182)
- Proteasome (179)
- One carbon pool by folate (175)
- Starch and sucrose metabolism (173)
- Graft-versus-host disease (171)
- beta-Alanine metabolism (170)
- Cysteine and methionine metabolism (163)
- Pentose phosphate pathway (158)
- Drug metabolism - other enzymes (155)
- Amino sugar and nucleotide sugar metabolism (153)
- Fructose and mannose metabolism (148)
- Linoleic acid metabolism (141)
- Citrate cycle (TCA cycle) (138)
- Regulation of autophagy (136)
- Circadian rhythm - mammal (127)
- Maturity onset diabetes of the young (124)
- Nicotinate and nicotinamide metabolism (122)
- Sphingolipid metabolism (118)
- Terpenoid backbone biosynthesis (117)
- Nitrogen metabolism (116)
- Galactose metabolism (114)
- Ribosome (114)
- Glycerophospholipid metabolism (108)
- Primary bile acid biosynthesis (102)
- SNARE interactions in vesicular transport (101)
- Aminoacyl-tRNA biosynthesis (97)
- Folate biosynthesis (96)
- Asthma (95)
- Fatty acid elongation in mitochondria (94)
- Sulfur metabolism (92)
- N-Glycan biosynthesis (91)
- Caffeine metabolism (85)
- Non-homologous end-joining (83)
- Porphyrin and chlorophyll metabolism (83)
- Olfactory transduction (80)
- Phenylalanine metabolism (80)
- Taste transduction (78)
- Synthesis and degradation of ketone bodies (75)
- Androgen and estrogen metabolism (70)
- Selenoamino acid metabolism (70)
- Other glycan degradation (68)
- Methane metabolism (65)
- Glyoxylate and dicarboxylate metabolism (59)
- Biosynthesis of unsaturated fatty acids (57)
- RNA polymerase (56)
- Glycosaminoglycan degradation (51)
- Ascorbate and aldarate metabolism (44)
- Pantothenate and CoA biosynthesis (42)
- Basal transcription factors (41)
- Ether lipid metabolism (40)
- Limonene and pinene degradation (40)
- Cyanoamino acid metabolism (39)
- Riboflavin metabolism (38)
- Pentose and glucuronate interconversions (37)
- Taurine and hypotaurine metabolism (36)
- O-Glycan biosynthesis (34)
- Steroid biosynthesis (30)
- Fatty acid biosynthesis (29)
- C21-Steroid hormone metabolism (28)
- Vitamin B6 metabolism (25)
- Glycosphingolipid biosynthesis - ganglio series (23)
- Glycosphingolipid biosynthesis - lacto and neolacto series (21)
- D-Glutamine and D-glutamate metabolism (20)
- Keratan sulfate biosynthesis (18)
- Thiamine metabolism (17)
- leucine and isoleucine biosynthesis (17)
- Chondroitin sulfate biosynthesis (14)
- alpha-Linolenic acid metabolism (13)
- Glycosphingolipid biosynthesis - globo series (12)
- Heparan sulfate biosynthesis (11)
- Protein export (10)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (9)
- Phenylalanine (9)
- tyrosine and tryptophan biosynthesis (9)
- Lysine biosynthesis (6)
- Biotin metabolism (5)
- O-Mannosyl glycan biosynthesis (3)
- Ubiquinone and other terpenoid-quinone biosynthesis (3)